Craneware plc AGM Statement (4950F)
17 Novembre 2020 - 8:00AM
UK Regulatory
TIDMCRW
RNS Number : 4950F
Craneware plc
17 November 2020
17 November 2020
Craneware plc
("Craneware" or the "Company")
AGM Statement
Craneware (AIM: CRW.L), the market leader in Value Cycle
software solutions for the US healthcare market, is pleased to
provide an update on trading ahead of its Annual General Meeting
taking place at 10am today. The AGM will be run as a "closed
meeting", with only the minimum required quorum of two shareholders
being present as is necessary to enable the formal business of the
meeting to be conducted.
The first four months of this fiscal year saw a return to strong
sales growth, considerably ahead of the equivalent period of the
prior year. Results are ahead of management expectations for this
stage in the year and , we expect revenues and adjusted EBITDA for
the Interim period to 31 December 2020 to be ahead of the
equivalent period in the prior year, building the foundation for a
return to double-digit growth in the future. We look forward to
providing further details within our Trading Update for the 6
months ended 31 December 2020.
Our Value Cycle offering, delivered via our cloud-based Trisus
platform, continues to resonate with the leadership teams of US
hospitals. Trisus provides the means to collect, analyse, compare,
verify, and correct their data, so they can improve the financial
and operational performance of their hospitals, while improving
patient outcomes.
With each hospital that joins the platform, Trisus becomes more
powerful. Through the recent beta launches of the Trisus (cloud)
versions of our core offerings, Chargemaster Toolkit and Pharmacy
Chargelink, and our four live Trisus native cloud applications, we
now have multiple means by which new and existing customers can
join the Trisus Community, providing them with a gateway to the
wider benefits the platform can provide.
We continue to see substantial new opportunities entering the
sales pipeline and the Board is confident in the continued strong
performance of the business.
For further information, please contact:
Craneware plc Peel Hunt Investec Bank Alma
(NOMAD & Joint (Joint Broker) (Financial PR)
Broker)
+44 (0)131 550 +44 (0)20 7418 +44 (0)20 7597 +44 (0)203 405
3100 8900 5970 0205
Keith Neilson, Dan Webster Patrick Robb Caroline Forde
CEO
Craig Preston, George Sellar Sebastian Lawrence Robyn Fisher
CFO
Andrew Clark Henry Reast Helena Bogle
Joe Pederzolli
About Craneware
Craneware (AIM: CRW.L), the leader in automated value cycle
solutions, collaborates with U.S. healthcare providers to plan,
execute and monitor value-based economic performance. Founded in
1999, Craneware is headquartered in Edinburgh, Scotland with
offices in Atlanta and Pittsburgh employing over 350 staff.
Craneware's value cycle management suite includes charge capture,
strategic pricing, patient engagement, claims analytics, revenue
recovery and retention, and cost and margin intelligence
solutions.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGMBIBDBLGBDGGL
(END) Dow Jones Newswires
November 17, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024